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Letter to the Editor, BJOG Exchange
Author's reply re: UK Criteria for Uterus Transplantation: A Review. (Response to BJOG-19-
0957)
To the Editor of BJOG,
I thank you for the opportunity to respond to the letter submitted in response to my original 
article ‘UK Criteria for Uterus Transplantation: A Review’.i I read with interest the letter as it 
is written by the members of the UK based team that are soon to conduct uterus 
transplants.ii The information has clarified and supported many of the points that I have 
raised within my article.
The response engages with three of the five criteria that I considered; the use of own ovum 
by recipients, the preference for a partner, and donors. The authors have taken the time to 
clarify and provided the medical justifications for these selection criteria for the research 
trials. Overall, the authors agree with my own recommendations on these three points; that 
whilst medical justification currently does not support the use of donor ovum this may be 
alleviated in the future; that ‘it is inappropriate and unjust to exclude single women, and 
potential recipients with appropriate social support should be eligible for UTx’, and that the 
use of deceased donors should be prioritised ‘if similar or superior outcomes are 
demonstrated’. As I also acknowledged, the authors note that the scarcity of deceased 
donors is a major limitation, and I welcome the news that the UK team are pursuing 
research into bioengineered uteri. Whilst not yet a realistic option, bioengineered uteri will 
overcome the concerns that I, and others, have raised about living donation.iii The thoughts 
of the UK team on the other two selection criteria that I also raised in my article would be 
welcomed.
What becomes apparent from the original article and the response letter, is that there is an 
ongoing tension between medical justifications for selection criteria, and legal and ethical 
justifications. In my article, the legal and ethical justifications for selection criteria were 
discussed, and the authors response engages with the medical justifications. This is 
understandable considering the different viewpoints and expertise from which we are 
writing.  It is not disputed that medical justifications for selection criteria that support the 
best interests of the participants are not appropriate, rather that as an outside (non-
medical) observer of uterus transplantation, greater engagement by the medical community 
with the legal and ethical principles and other stakeholders should be embraced. 
Interdisciplinary approaches are welcomed and encouraged, particularly in the sphere of 
reproductive medicine where medicine, ethics, law, religion, and cultural perspectives all 
have a role to play. It is recognised that the UK team have engaged with non-medical 
stakeholders,iv and I hope that this continues, both within the UK and with other teams 
worldwide. 
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